This site is intended for healthcare professionals

Medical Education
Specialty
Drugs
News
Congress

Search
Menu

Medical Education
Specialty
Drugs
News
Congress

Home
/
Medical Education
/
Antiplatelet therapy in ACS: Choices and Controver...
/
Videos
/
Controversies on choice of P2Y12 inhibitor: Are th...

Controversies on choice of P2Y12 inhibitor: Are the recommendations justifiable?

Antiplatelet therapy in ACS
ACS Patient Focus
Expert Opinion
ESC 2022 Highlights

Controversies on choice of P2Y12 inhibitor

Personalised to support your treatment decisions

Specialty
Congress
News & Insights
Education
About us

© Medthority 2024 | Medthority.com

Privacy policy
Terms of use
Contact us